The continuous innovation in pharmaceuticals demands high-quality building blocks for life-saving medications. Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid (CAS 486460-00-8) stands out as a crucial intermediate in the synthesis of Sitagliptin, a widely recognized treatment for type 2 diabetes. This article highlights the importance of this chemical intermediate and its contribution to modern diabetes therapy, offering insights for both research and procurement professionals.
Sitagliptin: A Breakthrough in Diabetes Management
Sitagliptin, marketed under various brand names, belongs to the class of DPP-4 inhibitors. By blocking the DPP-4 enzyme, it enhances the body's own incretin system, leading to improved glycemic control. The development of such effective treatments relies heavily on the availability of precisely synthesized chemical intermediates. The trifluorophenyl group and the specific stereochemistry of the amino acid backbone are essential features of Sitagliptin, which are introduced via intermediates like Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid.
The Role of the Intermediate in Synthesis
As a pharmaceutical intermediate, Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid serves as a foundational component. Its precise molecular structure, including the Boc protection group which is later removed, and the trifluorinated phenyl ring are designed to be incorporated into the final Sitagliptin molecule through a series of controlled chemical reactions. The quality of this intermediate directly influences the efficiency and purity of the final drug product. For R&D scientists, reliable access to this compound is vital for process development and optimization.
Ensuring Quality and Supply
When you purchase Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid, prioritizing a reputable supplier is paramount. A good supplier will guarantee high purity (often stated as ≥99%), consistent batch-to-batch quality, and adherence to safety standards. Understanding the origin and manufacturing practices of the manufacturer, especially those based in China, can provide confidence in the product's reliability. Competitive pricing should always be balanced with a commitment to quality assurance.
Contributing to Global Health
By providing this essential intermediate, we play a role in ensuring that patients have access to effective diabetes treatments. Our commitment as a supplier is to uphold the highest standards in chemical manufacturing, supporting the pharmaceutical industry's mission to improve global health. We aim to be your trusted partner for all your Sitagliptin intermediate needs.
For reliable sourcing of Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid, we invite you to connect with us. We offer quality, consistency, and competitive advantages to support your pharmaceutical manufacturing.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.